医療ロボット市場は、予測期間中に15.69％という最大のCAGRを記録すると予想されます。医療ロボットの利用拡大は、医療ロボット市場の発展を推進する主な要因の1つです。同様に、機械的な進歩と主要ドライブの拡大によって、予測期間中における世界市場の成長がさらに促進されます。
手術用ロボット工学は、現在の医療処置におけるもう 1 つの開発ポイントおよび機械孵化場として登場しました。ロボット支援医療処置は、患者に対してオープン処置を実施しながら専門家の能力を拡大するため、または既存のさほど差し支えのない医療処置の革新の限界に対処するために作成されました。外科用ロボットを使用した目立たない医療処置は、回復時間を短縮し、修復を早め、瘢痕化を回避するのに役立ちます。無視できるほど目立たない外科治療に対する要件の拡大と、手術戦略を支援する医療ロボットの利用は、基本的に外科活動の実行可能性に取り組んでいます。このように、前述の要因により市場の拡大が進んでいます。
目次
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 LIST OF ASSUMPTIONS
2 RESEARCH METHODOLOGY
2.1 OVERVIEW
2.2 DATA MINING
2.3 SECONDARY RESEARCH
2.4 PRIMARY RESEARCH
2.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
2.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
2.5 FORECASTING TECHNIQUES
2.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
2.6.1 BOTTOM-UP APPROACH
2.6.2 TOP-DOWN APPROACH
2.7 DATA TRIANGULATION
2.8 VALIDATION
3 MARKET DYNAMICS
3.1 OVERVIEW
3.2 DRIVERS
3.2.1 GROWING APPLICATIONS OF ROBOTS IN HEALTHCARE
3.2.2 GROWING INITIATIVES AND DEVELOPMENT MOVEMENTS IN THE MARKET HELPS IN THE GROWTH
3.2.3 TECHNOLOGICAL ADVANCEMENTS IN MEDICAL ROBOTICS
3.3 RESTRAINTS
3.3.1 HIGH COST OF ROBOTS
3.4 OPPORTUNITIES
3.4.1 RISING DEMAND FOR AUTOMATION
4 MARKET FACTOR ANALYSIS
4.1 VALUE CHAIN ANALYSIS
4.1.1 R&D AND DESIGNING
4.1.2 MANUFACTURING
4.1.3 DISTRIBUTION & SALES
4.1.4 POST-SALES SERVICES AND REVIEW
4.2 PORTER'S FIVE FORCES MODEL
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 BARGAINING POWER OF SUPPLIERS
4.2.3 THREAT OF SUBSTITUTES
4.2.4 BARGAINING POWER OF BUYERS
4.2.5 INTENSITY OF RIVALRY
4.3 IMPACT OF COVID-19
4.3.1 OVERVIEW
4.3.2 IMPACT ON DEMAND
4.3.3 IMPACT ON THE SUPPLY CHAIN
4.3.4 IMPACT ON KEY PLAYERS
4.4 MEDICAL ROBOTIC SYSTEMS INSTALLED BASE AND ASP
5 GLOBAL MEDICAL ROBOTICS MARKET, BY TYPE
5.1 OVERVIEW
5.2 EQUIPMENT
5.3 SERVICE
5.4 CONSUMABLES
6 GLOBAL MEDICAL ROBOTICS MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 SURGICAL ROBOTS
6.3 REHABILITATION ROBOTS
6.4 NONINVASIVE RADIOSURGERY ROBOTS
6.5 HOSPITAL AND PHARMACY ROBOTS
6.6 EMERGENCY RESPONSE ROBOTIC SYSTEMS
6.7 LOGISTICS/HANDLING ROBOTIC SYSTEMS
6.8 IMAGING ROBOTIC SYSTEMS
7 GLOBAL MEDICAL ROBOTICS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 NEUROLOGY
7.3 ONCOLOGY
7.4 ORTHOPEDIC ROBOTIC SYSTEMS
7.5 LAPAROSCOPY
7.6 CARDIOLOGY
7.7 AESTHETIC SURGERY
7.8 REHABILITATION
7.9 ANGIOGRAPHY
7.10 OTHERS
8 GLOBAL MEDICAL ROBOTICS MARKET, BY SETTING
8.1 OVERVIEW
8.2 HOME-CARE
8.3 IN-PATIENT
8.4 OUT-PATIENT
9 GLOBAL MEDICAL ROBOTICS MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS & CLINICS
9.3 SPECIALTY CENTERS
9.4 REHABILITATION CENTERS
9.5 OTHERS
10 GLOBAL MEDICAL ROBOTICS MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 PORTUGAL
10.3.7 RUSSIA
10.3.8 NETHERLANDS
10.3.9 CZECH REPUBLIC
10.3.10 SWITZERLAND
10.3.11 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 CHINA
10.4.2 INDIA
10.4.3 JAPAN
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 INDONESIA
10.4.7 PHILIPPINES
10.4.8 MALAYSIA
10.4.9 SINGAPORE
10.4.10 REST OF ASIA-PACIFIC
10.5 REST OF THE WORLD
10.5.1 MIDDLE EAST
10.5.2 AFRICA
10.5.3 LATIN AMERICA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE MEDICAL ROBOTICS MARKET
11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE MEDICAL ROBOTICS MARKET
11.5 KEY DEVELOPMENT ANALYSIS
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
11.6.1 PRODUCT APPROVALS AND PRODUCT LAUNCHES
11.6.2 INVESTMENTS/FUNDING
11.6.3 BUSINESS EXPANSION
11.6.4 MERGERS & ACQUISITIONS
11.7 MAJOR PLAYERS SALES ANALYSIS
11.7.1 SALES & OPERATING INCOME
11.8 MAJOR PLAYERS R&D ANALYSIS
12 COMPANY PROFILE
12.1 AURIS HEALTH, INC.
12.1.1 COMPANY OVERVIEW
12.1.2 FINANCIAL OVERVIEW
12.1.3 PRODUCTS/SERVICES OFFERED
12.1.4 KEY DEVELOPMENTS
12.1.5 KEY STRATEGIES
12.2 MEDTRONIC
12.2.1 COMPANY OVERVIEW
12.2.2 FINANCIAL OVERVIEW
12.2.3 PRODUCTS OFFERED
12.2.4 KEY DEVELOPMENTS
12.2.5 SWOT ANALYSIS
12.2.6 KEY STRATEGIES
12.3 ZIMMER BIOMET
12.3.1 COMPANY OVERVIEWS
12.3.2 FINANCIAL OVERVIEW
12.3.3 PRODUCTS OFFERED
12.3.4 KEY DEVELOPMENTS
12.3.5 SWOT ANALYSIS
12.3.6 KEY STRATEGIES
12.4 RENISHAW PLC.
12.4.1 COMPANY OVERVIEW
12.4.2 FINANCIAL OVERVIEW
12.4.3 PRODUCTS OFFERED
12.4.4 KEY DEVELOPMENTS
12.4.5 KEY STRATEGIES
12.5 HEALTH ROBOTICS S.R.L
12.5.1 COMPANY OVERVIEW
12.5.2 FINANCIAL OVERVIEW
12.5.3 PRODUCTS OFFERED
12.5.4 KEY DEVELOPMENTS
12.5.5 KEY STRATEGIES
12.6 STRYKER
12.6.1 COMPANY OVERVIEW
12.6.2 FINANCIAL ANALYSIS
12.6.3 PRODUCTS OFFERED
12.6.4 KEY DEVELOPMENTS
12.6.5 SWOT ANALYSIS
12.6.6 KEY STRATEGIES
12.7 SMITH+NEPHEW
12.7.1 COMPANY OVERVIEW
12.7.2 FINANCIAL OVERVIEW
12.7.3 PRODUCTS OFFERED
12.7.4 KEY DEVELOPMENTS
12.7.5 SWOT ANALYSIS
12.7.6 KEY STRATEGIES
12.8 INTUITIVE SURGICAL
12.8.1 COMPANY OVERVIEW
12.8.2 FINANCIAL OVERVIEW
12.8.3 PRODUCTS 0FFERED
12.8.4 KEY DEVELOPMENTS
12.8.5 SWOT ANALYSIS
12.8.6 KEY STRATEGIES
12.9 KUKA AG
12.9.1 COMPANY OVERVIEW
12.9.2 FINANCIAL OVERVIEW
12.9.3 PRODUCTS OFFERED
12.9.4 KEY DEVELOPMENTS
12.9.5 KEY STRATEGIES
12.10 CMR SURGICAL
12.10.1 COMPANY OVERVIEW
12.10.2 FINANCIAL ANALYSIS
12.10.3 PRODUCTS OFFERED
12.10.4 KEY DEVELOPMENTS
12.10.5 KEY STRATEGIES
13 APPENDIX
13.1 REFERENCES
13.2 RELATED REPORTS
